Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Decensi

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1986
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancerG Robustelli della Cuna, P Zanon, L Pavesi, et al.
Journal of the National Cancer Institute|February 3, 2000
Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?U Veronesi, G De Palo, E Marubini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1994
Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patientsR Torrisi, S Parodi, V Fontana, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of navelbine in advanced renal cell carcinomaL Canobbio, F Boccardo, D Guarneri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trialA Decensi, R Torrisi, V Fontana, et al.
Acta Endocrinologica|October 1, 1993
Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancerA Decensi, R Torrisi, V Fontana, et al.
Cancer Research|October 15, 1993
The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patientsR Torrisi, F Pensa, M A Orengo, et al.
Cancer Detection and Prevention|November 4, 2000
Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancerL Baglietto, R Torrisi, G Arena, et al.
British Journal of Cancer|December 19, 2001
Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancerR Torrisi, L Baglietto, H Johansson, et al.
Cancer Research|February 15, 1995
Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiationM Ponzoni, P Bocca, V Chiesa, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1986
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancerG Robustelli della Cuna, P Zanon, L Pavesi, et al.
Journal of the National Cancer Institute|February 3, 2000
Re: Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?U Veronesi, G De Palo, E Marubini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1994
Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patientsR Torrisi, S Parodi, V Fontana, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of navelbine in advanced renal cell carcinomaL Canobbio, F Boccardo, D Guarneri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Correlation between plasma transforming growth factor-beta 1 and second primary breast cancer in a chemoprevention trialA Decensi, R Torrisi, V Fontana, et al.
Acta Endocrinologica|October 1, 1993
Long-term endocrine effects of administration of either a non-steroidal antiandrogen or a luteinizing hormone-releasing hormone agonist in men with prostate cancerA Decensi, R Torrisi, V Fontana, et al.
Cancer Research|October 15, 1993
The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patientsR Torrisi, F Pensa, M A Orengo, et al.
Cancer Detection and Prevention|November 4, 2000
Ocular effects of fenretinide, a vitamin A analog, in a chemoprevention trial of bladder cancerL Baglietto, R Torrisi, G Arena, et al.
British Journal of Cancer|December 19, 2001
Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancerR Torrisi, L Baglietto, H Johansson, et al.
Cancer Research|February 15, 1995
Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiationM Ponzoni, P Bocca, V Chiesa, et al.
Pageof 10